天安新材(603725.SH):獲得“一種裝飾材料及其製備方法”發明專利
格隆匯9月14日丨天安新材(603725.SH)公佈,公司於近日收到了中華人民共和國國家知識產權局頒發的發明專利證書,具體如下:
證書號:第3951203號
發明名稱:一種裝飾材料及其製備方法
專利號:ZL201710852228.7
專利申請日:2017年09月19日
專利權人:廣東天安新材料股份有限公司
授權公告日:2020年08月21日
專利權期限:20年(自申請日起算)
本項發明專利的取得是公司重要核心技術的體現和延伸,本次專利的獲得不會對公司近期經營產生重大影響,但有利於進一步完善公司知識產權保護體系,發揮自主知識產權的技術優勢,促進技術創新,從而提升公司核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.